Interview with Hyun Ho Jung, CEO, Medy-Tox
What drove you to make the move from the academia to the business sector when you decided to establish Medy-Tox in 2000? I founded Medy-tox in the year 2000, in…
Address: Ochang Science Industry Complex 641-4 Gak-ri, Ochang-eup, Chungbuk 363-883, Republic of Korea
Tel: +82-43-217-1555
Web: http://www.medy-tox.co.kr/
Medy-Tox is a biotech venture company established in 2000 with a goal of developing botulinum toxin-based injections. Through the hard work and dedication of our employees, MEDITOXIN (‘NEURONOX, in the overseas market) was developed in 2006. MEdy -Tox’s products are very popular with not only domestic customers but also overseas customers and the demand for them is rapidly increasing annually. Medy Tox aims to become the best bio pharmaceutical manufacturer in Republic of Korea and to compete with the world’s biotech venture company. Medy Tox’s genuine efforts on next-generation botulinum products have been paying off one by one. Meditox will be able to provide our customers with a different product every year.
What drove you to make the move from the academia to the business sector when you decided to establish Medy-Tox in 2000? I founded Medy-tox in the year 2000, in…
Could you introduce Lee & Ko to our readers? Established in 1977, Lee & Ko is the largest and the leading law firm in Korea, consisting of 310 professionals, including…
South Korea has a short history of participating in global clinical trials, but now the country is seeing exponential growth in this area. What has changed in recent years leading…
What are the main milestones and achievements of Daewoong’s pharmaceutical business over its decades of evolution? Daewoong was first established in 1945 as Chosun Liver-oil Pharmaceutical Industry Co., Ltd. The…
Could you provide our international readers with a profile of Bioneer as it stands today? Bioneer, having a strong basis of technology and experiences in molecular biology since 1992, we…
Although Chungcheongbuk-do is a small province in terms of territory and population, it has gained increasing importance in Korea’s economy. What are the main drivers of this growing economic progression?…
How did you first get involved in clinical trials and what inspired you to create your own CRO, ADM Korea? When I was working at CJ, the company was starting…
Though you have recently been appointed as President of KRIBB, your history with the institute goes quite far back. Could you please briefly explain the role it plays within South…
Could you please introduce Shinpoong, which you founded in 1962, and mention the main milestones of this unique company in the Korean pharmaceutical industry? I founded Shinpoong in a very…
Novartis’ Head Office in Basel, Switzerland as well as several prior international assignments in Asia and Europe. What do you find as the most interesting particularities of the pharmaceutical sector…
Please introduce the Korean Food and Drug Administration (KFDA) and its main health-related responsibilities within the Korean government… The KFDA’s main duty is to cooperate and support with domestic and…
How would you rate South Korea’s healthcare system when compared to regional peers and other OECD countries – main strong points and room for improvement? Since the introduction of the…
You have a very long track record working with Novo Nordisk in Asia. What is your perspective on the Diabetes explosion that has been taking place in this part of…
See our Cookie Privacy Policy Here
